MGNet: Assessing High-Dose Chemotherapy and Hematopoietic Cell Transplantation in Severe Myasthenia Gravis
Nov 14, 2023 ·
1m 59s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Annals of Clinical and Translational Neurology on September 19,...
show more
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Annals of Clinical and Translational Neurology on September 19, 2023, titled "Remission of severe myasthenia gravis after autologous stem cell transplantation."
Read the paper here: https://onlinelibrary.wiley.com/doi/10.1002/acn3.51898
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
show less
Read the paper here: https://onlinelibrary.wiley.com/doi/10.1002/acn3.51898
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
Information
| Author | RDCRN |
| Organization | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
